Breast Tumor Characterization Using [ 18 F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics

• Published in: Cancers 2021-03, Vol.13 (6), p.1249
• Main Authors: Krajnc, Denis, Papp, Laszlo, Nakuz, Thomas S, Magometschnigg, Heinrich F, Grahovac, Marko, Spielvogel, Clemens P, Ecsedi, Boglarka, Bago-Horvath, Zsuzsanna, Haug, Alexander, Karanikas, Georgios, Beyer, Thomas, Hacker, Marcus, Helbich, Thomas H, Pinker, Katja
• Format: Article
• Language: English
• Subjects: Age; Algorithms; Biopsy; Body mass index; Breast cancer; Cancer therapies; Computed tomography; Data processing; Estrogens; Gene amplification; Learning algorithms; Machine learning; Mammography; Metastasis; Patients; Positron emission tomography; Prediction models; Radiomics; Standardization; Tomography; Tumors
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13061249

: This study investigated the performance of ensemble learning holomic models for the detection of breast cancer, receptor status, proliferation rate, and molecular subtypes from [ F]FDG-PET/CT images with and without incorporating data pre-processing algorithms. Additionally, machine learning (ML) models were compared with conventional data analysis using standard uptake value lesion classification. : A cohort of 170 patients with 173 breast cancer tumors (132 malignant, 38 benign) was examined with [ F]FDG-PET/CT. Breast tumors were segmented and radiomic features were extracted following the imaging biomarker standardization initiative (IBSI) guidelines combined with optimized feature extraction. Ensemble learning including five supervised ML algorithms was utilized in a 100-fold Monte Carlo (MC) cross-validation scheme. Data pre-processing methods were incorporated prior to machine learning, including outlier and borderline noisy sample detection, feature selection, and class imbalance correction. Feature importance in each model was assessed by calculating feature occurrence by the R-squared method across MC folds. : Cross validation demonstrated high performance of the cancer detection model (80% sensitivity, 78% specificity, 80% accuracy, 0.81 area under the curve (AUC)), and of the triple negative tumor identification model (85% sensitivity, 78% specificity, 82% accuracy, 0.82 AUC). The individual receptor status and luminal A/B subtype models yielded low performance (0.46-0.68 AUC). SUV model yielded 0.76 AUC in cancer detection and 0.70 AUC in predicting triple negative subtype. : Predictive models based on [ F]FDG-PET/CT images in combination with advanced data pre-processing steps aid in breast cancer diagnosis and in ML-based prediction of the aggressive triple negative breast cancer subtype.